Nanomedicine-based commercial formulations: current developments and future prospects.

Area of Science:

• Nanomedicine
• Drug Delivery Systems
• Biotechnology

Background:

• Nanomedicine formulations have increased significantly due to advantages in controlled/targeted drug delivery.
• These formulations offer enhanced efficacy and reduced toxicity, making them suitable for treating complex diseases like cancer.

Purpose of the Study:

• To review nanomedicine-based formulation development.
• To discuss approved and marketed nanomedicines.
• To explore challenges and future prospects in nanomedicine.

Main Methods:

• Literature review of nanomedicine formulations.
• Analysis of approved nanomedicines by regulatory agencies (FDA, EMA).
• Discussion of challenges in characterization, reproducibility, and biological evaluation.

Main Results:

• Several nanomedicines are approved and commercially available.
• Critical challenges remain, including reproducibility and proper characterization.
• Rigorous studies and stringent guidelines are necessary for safe and effective nanomedicine development.

Conclusions:

• Nanomedicines hold significant therapeutic potential, particularly for challenging diseases.
• Addressing current challenges is crucial for advancing nanomedicine applications.
• Further research is warranted to optimize the use of nanomedicine formulations.